Team | Endurance | Tactical/technical | Paralympic | Total cohort | |
---|---|---|---|---|---|
n=30 | n=53 | n=36 | n=26 | n=142 | |
Health problems reported | |||||
All | 45 (42–48)**,***,**** | 30 (27–32)*,*** | 25 (21–28)*,** | 29 (26–33)* | 36 (34–38) |
Illness | 6 (5–8)**,***,**** | 16 (13–18)*,*** | 10 (9–12)*,**,**** | 16 (14–19)*,*** | 13 (12–14) |
Injury | 42 (39–45)**,***,**** | 17 (16–19)* | 18 (14–22)* | 19 (17–21)* | 25 (24–27) |
Overuse injury | 31 (29–33)**,***,**** | 15 (13–17)* | 16 (13–18)* | 13 (12–14)*,** | 20 (18–21) |
Acute injury | 10 (8–12)**,***,**** | 2 (1–2)* | 3 (2–4)* | 2 (1–3)* | 4 (3–5) |
Substantial problems | |||||
All | 16 (14–17)*** | 14 (13–16)*** | 11 (9–13)*,**,**** | 16 (14–19)*** | 15 (14–16) |
Illness | 2 (1–3)**,***,**** | 8 (6–10)* | 6 (5–8)* | 8 (6–10)* | 6 (6–7) |
Injury | 14 (13–16)**,***,**** | 7 (6–7)* | 5 (4–7)*,**,**** | 11 (9–12)*,**,*** | 9 (9–10) |
Overuse injury | 9 (8–11)**,*** | 6 (5–6)* | 4 (3–5)*,**,**** | 10 (8–11)**,*** | 7 (6–8) |
Acute injury | 5 (4–6)**,***,**** | 1 (0–1)* | 2 (1–2)* | 1 (0–2)* | 2 (2–3) |
p<0.05 vs *team group, **endurance group, ***tactical/technical group, ****paralympic group.
All data are mean values with 95% CI in parenthesis. Substantial problem: causing moderate/severe reductions in training volume or sports performance, or complete inability to participate in training or competition.